X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (410) 410
Publication (61) 61
Book Review (17) 17
Book Chapter (12) 12
Magazine Article (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
causes of (276) 276
index medicus (244) 244
humans (209) 209
research (180) 180
animals (168) 168
neurosciences (140) 140
male (113) 113
health aspects (112) 112
care and treatment (103) 103
brain (95) 95
physiological aspects (92) 92
clinical neurology (91) 91
risk factors (88) 88
female (84) 84
rats (74) 74
oxidative stress (68) 68
mice (65) 65
apoptosis (61) 61
analysis (60) 60
neuroprotection (60) 60
complications and side effects (57) 57
neurology (49) 49
genetic aspects (48) 48
stroke (47) 47
rodents (46) 46
usage (46) 46
neurons (45) 45
mortality (44) 44
diagnosis (43) 43
ischemia (42) 42
middle aged (42) 42
inflammation (40) 40
injuries (40) 40
research article (40) 40
aged (39) 39
disease models, animal (39) 39
medicine (39) 39
adult (37) 37
development and progression (37) 37
cell biology (36) 36
nervous system (36) 36
proteins (35) 35
multidisciplinary sciences (33) 33
biochemistry & molecular biology (32) 32
cell death (32) 32
parkinson's disease (32) 32
rats, sprague-dawley (32) 32
studies (31) 31
article (30) 30
brain damage (30) 30
drug therapy (30) 30
gene expression (30) 30
psychiatry (29) 29
alzheimer's disease (28) 28
cause of death (28) 28
prevention (28) 28
traumatic brain injury (28) 28
expression (26) 26
pharmacology & pharmacy (26) 26
biomedicine (25) 25
critical care medicine (25) 25
dosage and administration (25) 25
neuroprotective agents - therapeutic use (25) 25
central-nervous-system (24) 24
neurodegeneration (24) 24
review (24) 24
alzheimers-disease (23) 23
antioxidants (23) 23
medicine, research & experimental (23) 23
neuroprotective agents - pharmacology (23) 23
all-cause mortality (22) 22
endocrinology & metabolism (22) 22
patient outcomes (22) 22
disease (21) 21
mice, inbred c57bl (21) 21
neurology. diseases of the nervous system (21) 21
surgery (21) 21
cytokines (20) 20
medicine, general & internal (20) 20
pathogenesis (20) 20
science (20) 20
activation (19) 19
apoptosis - drug effects (19) 19
brain - metabolism (19) 19
degeneration (19) 19
original articles (19) 19
aged, 80 and over (18) 18
cerebral-ischemia (18) 18
dementia (18) 18
diabetes (18) 18
immunohistochemistry (18) 18
immunology (18) 18
in-vivo (18) 18
mutation (18) 18
nervous system diseases (18) 18
neurodegenerative diseases (18) 18
pathology (18) 18
prognosis (18) 18
abridged index medicus (17) 17
brain - pathology (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, p. e46092
Background: Ischemic postconditioning (IPOC), or relief of ischemia in a stuttered manner, has emerged as an innovative treatment strategy to reduce programmed... 
INFARCT SIZE | PATHWAYS | STROKE | ISCHEMIA/REPERFUSION INJURY | HYPOXIA-ISCHEMIA | MULTIDISCIPLINARY SCIENCES | IN-VIVO | NEURON DEATH | MODEL | BRAIN | CELL-DEATH | Beclin-1 | Sirolimus - therapeutic use | Adenine - analogs & derivatives | Ischemic Postconditioning - methods | Microtubule-Associated Proteins - genetics | Immunosuppressive Agents - therapeutic use | Brain Ischemia - genetics | Rats | Male | Adenine - pharmacology | Brain Ischemia - prevention & control | Rats, Sprague-Dawley | Sirolimus - pharmacology | Autophagy - drug effects | Brain - drug effects | Up-Regulation - drug effects | Brain - blood supply | Animals | Adenine - therapeutic use | Brain Ischemia - pathology | Apoptosis Regulatory Proteins - genetics | Brain - pathology | Immunosuppressive Agents - pharmacology | Proto-Oncogene Proteins c-bcl-2 - genetics | Stroke (Disease) | Autophagy (Cytology) | Care and treatment | Cerebral ischemia | Causes of | Diagnosis | Research | Occlusion | Neuroprotection | Brain | Bcl-2 protein | Phagosomes | Homeostasis | Activation | Biochemistry | Autophagy | Proteins | Reperfusion | Ischemia | Cerebral blood flow | Rodents | Inhibition | Carotid artery | Edema | Stroke | Pharmacology | Rapamycin | Neurology | Injury prevention | Brain research | Cell death | Hypoxia | Molecular biology | Endoplasmic reticulum | Brain injury | Phagocytosis | Apoptosis
Journal Article
Molecular Neurodegeneration, ISSN 1750-1326, 2009, Volume 4, Issue 1, pp. 16 - 16
Journal Article
中国神经再生研究:英文版, ISSN 1673-5374, 2018, Volume 13, Issue 2, pp. 228 - 229
Retinal ganglions cells (RGCs) are responsible for propagating electrochemical information from the eye to the brain along their axons which make up the optic... 
干细胞;生长因素;膜;RGC;电气化学;神经病;损失 | GLAUCOMA | NEUROSCIENCES | CELL BIOLOGY | Glaucoma | Retinal ganglion cells | Care and treatment | Patient outcomes | Stem cells | Causes of | Transplantation | Health aspects | Growth factors
Journal Article
Brain Research, ISSN 0006-8993, 2009, Volume 1285, pp. 14 - 21
Abstract Earlier studies from this and other laboratories show that ethanol induces apoptotic death of fetal and neonatal neurons. One mechanism that underlies... 
Neurology | Neuroprotection | Melatonin | Ethanol | Antioxidant | Apoptosis | N-acetylcysteine | FETAL RHOMBENCEPHALIC NEURONS | RECEPTOR CAUSES SUPPRESSION | NEUROSCIENCES | CEREBELLAR GRANULE CELLS | CAUSES MITOCHONDRIAL DYSFUNCTION | SEROTONIN(1A) RECEPTOR | MATERNAL IPSAPIRONE TREATMENT | INDUCED OXIDATIVE STRESS | ACETYL-L-CYSTEINE | SUPEROXIDE-DISMUTASE | ALCOHOL EXPOSURE | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Oxidative Stress - physiology | Cytoprotection - physiology | Hippocampus - drug effects | Apoptosis Regulatory Proteins - drug effects | Nerve Degeneration - chemically induced | Nerve Degeneration - metabolism | Alcohol-Induced Disorders, Nervous System - metabolism | Neuroprotective Agents - pharmacology | Cytoprotection - drug effects | Female | Acetylcysteine - therapeutic use | Cell Line | Central Nervous System Depressants - antagonists & inhibitors | Gene Expression Regulation - genetics | Antioxidants - pharmacology | Prenatal Exposure Delayed Effects - drug therapy | Hippocampus - cytology | Prenatal Exposure Delayed Effects - metabolism | Apoptosis Regulatory Proteins - metabolism | Gene Expression Regulation - drug effects | Pregnancy | Hippocampus - metabolism | Alcohol-Induced Disorders, Nervous System - drug therapy | Reactive Oxygen Species - antagonists & inhibitors | Animals | Acetylcysteine - pharmacology | Melatonin - therapeutic use | Alcohol-Induced Disorders, Nervous System - physiopathology | Mice | Apoptosis - physiology | Oxidative Stress - drug effects | Ethanol - antagonists & inhibitors | Melatonin - pharmacology | Nerve Degeneration - drug therapy | Prenatal Exposure Delayed Effects - chemically induced | Antioxidants | Phosphatidylinositol | Cell research | Neurons | Acetylcysteine | Glutathione | Index Medicus | apoptosis | antioxidant | melatonin | ethanol | neuroprotection
Journal Article
Neurochemical Research, ISSN 0364-3190, 10/2010, Volume 35, Issue 10, pp. 1546 - 1556
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 11/2011, Volume 204, Issue 10, pp. 1563 - 1572
Journal Article
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 08/2014, Volume 27, Issue 8, pp. 1036 - 1044
BACKGROUND Stroke is a leading cause of death and disability; however, meta-analysis of randomized controlled trials of blood pressure-lowering drugs in acute... 
Hypertension | Neuroprotection | Stroke | Acute C21 treatment | Cerebral blood flow | Blood pressure | Blood-brain barrier permeability | Inflammation | MORTALITY | blood pressure | GAMMA ACTIVATION | DIABETIC MICE | FOCAL CEREBRAL-ISCHEMIA | INJURY | PREVENTION | stroke | AT receptor stimulation | CONSCIOUS RATS | blood-brain barrier permeability | CAUSES NEUROPROTECTION | MORBIDITY | inflammation | neuroprotection | acute C21 treatment | cerebral blood flow | PERIPHERAL VASCULAR DISEASE | hypertension | EXPRESSION | Receptor, Angiotensin, Type 2 - agonists | Receptor, Angiotensin, Type 2 - genetics | Mice, Inbred C57BL | Male | Cerebrovascular Circulation | Stroke - drug therapy | Infarction, Middle Cerebral Artery - pathology | Mice, Knockout | Stroke - pathology | Animals | Infarction, Middle Cerebral Artery - complications | Brain Ischemia - drug therapy | Brain Ischemia - pathology | Superoxides - metabolism | Brain - pathology | Nervous System Diseases - etiology | Mice | Nervous System Diseases - physiopathology | Blood-Brain Barrier | Stroke (Disease) | Prevention | Complications and side effects | Receptors | Patient outcomes | Angiotensin II receptor blockers | Angiotensin | Brain damage | Dosage and administration | Health aspects | Risk factors | Proteins | Ischemia | Diabetes | Gene expression | Drug dosages
Journal Article